The R&D center of Sichuan Aupone Pharmaceutical is focusing on the research and development of distinctive, challenging APIs and pharmaceuticals.

In a win-win cooperation, the R&D center collaborates with a number of well-known academic institutions, namely, Sichuan University, Nanjing Medical University, Shenyang Pharmaceutical University, and etc. to form a strong R&D system. Meanwhile, sharing complementary R&D resources, it cooperates with other pharmaceutical R&D institutions, such as Beijing Yeedozencom, Chengdu Sintanovo, Shanghai Medicilon, Beijing Yinuotai, and Chengdu Sainuoxiya.

Based in the laboratories of more than 2000 square meters, the R&D center possesses various high-end equipment such as LC-MS/MS, GC-MS/MS, ICP-MS, DSC, UPLC, ion chromatograph, and etc., which set the solid foundation for its continuous technology advancement in the future. 

There are currently more than 20 research projects in various fields such as the mental nervous system, cardiovascular and cerebrovascular, anti-allergic, anti-viral, anti-coagulation, digestion, and endocrine.

The R&D center is committed to the research of innovative drug with independent intellectual property rights and maintaining the strong competitiveness in antipsychotic medication. With continuous investment and research in high-tech APIs and pharmaceuticals in the fields as antipsychotic, cardiovascular, anti-allergic, anti-viral, anti-coagulant, digestive, and endocrine, the R&D center keeps refreshing the research pipelines with competitive products.